In the attempt to classify most common urological diseases in neonates the authors have summarized more than 700 cases. The examinees' age ranged from a few hours to four months. The diagnosis was made antenatally or early in postnatal life according to the leading symptoms of abdominal, uropoietic, urination and urine quality defects. Depending on the urinary damage at different stages of intra- and extrauterine development and time of primary symptoms recognition, the authors propose to distinguish antenatal, intranatal and postnatal lesions. These include congenital conditions, dysfunctions, conditions caused by tissue and system immaturity, etc. Instructions on the choice of optimal therapeutic policy for each group are given.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
The dilemma of X-linked agammaglobulinemia carriers.
J Allergy Clin Immunol Glob
February 2025
Department of Molecular Medicine, Sapienza University, Rome, Italy.
Background: Many patients with X-linked agammaglobulinemia (XLA) nowadays have reached adulthood, as well as their sisters, possibly carriers of a deleterious Bruton tyrosine kinase variant. Studies on motherhood outcomes in families with XLA are lacking.
Objective: We sought to investigate adherence to carrier status screening, interest in preconception and prenatal genetic counseling, and reproductive decisions in relatives with XLA.
SHOULD AN ACCESSORY RENAL ARTERY BE CONSIDERED AS A CAUSE OF HYPERTENSION IN ADOLESCENTS: A CASE REPORT.
Acta Clin Croat
December 2023
Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
The role of an accessory renal artery in the pathogenesis of hypertension is still controversial. In this report, we describe a previously healthy 16-year-old girl with an accessory right renal artery who presented with hypertensive urgency (no progressive target organ dysfunction). Initial workup other than hypercholesterolemia and mild proteinuria was normal with no signs of other target organ damage.
View Article and Find Full Text PDFURINARY NEPHRIN AS AN EARLY BIOMARKER OF HYPERTENSIVE NEPHROPATHY.
Acta Clin Croat
December 2023
Department of Digestive Surgery, Faculty of Medicine, Ss Cyril and Methodius University, Skopje, North Macedonia.
Hypertensive nephropathy (HN) is characterized by kidney damage due to chronic high blood pressure. Podocytes play a crucial role in the pathogenesis of HN, thus, nephrin could be important in the early diagnosis of HN. The aim of the study was to investigate the association of urinary nephrin (u-nephrin) levels with clinical and laboratory characteristics in patients with HN and to test diagnostic relevance of u-nephrin as an early biomarker of HN.
View Article and Find Full Text PDFA nomogram for predicting bladder dysfunction in patients with type 2 diabetes mellitus: a retrospective study.
PeerJ
January 2025
Department of Nursing, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Background: Diabetic bladder dysfunction (DBD) is a common urinary complication in diabetic patients, significantly affecting their overall well-being and quality of life, and placing a considerable burden on healthcare resources. Early prevention is crucial; however, the absence of a simple and effective tool to predict DBD onset remains a significant challenge. This study aims to identify risk factors for DBD in patients with type 2 diabetes mellitus (T2DM) and to develop a predictive nomogram for clinical application.
View Article and Find Full Text PDFEGR1 inhibits clear cell renal cell carcinoma proliferation and metastasis via the MAPK15 pathway.
Oncol Res
January 2025
Department of Urology, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
Background: Clear cell renal carcinoma (ccRCC), the leading histological subtype of RCC, lacks any targeted therapy options. Although some studies have shown that early growth response factor 1 (EGR1) has a significant role in cancer development and progression, its role and underlying mechanisms in ccRCC remain poorly understood.
Methods: The Cancer Genome Atlas (TCGA) database was utilized to examine the expression of EGR1 in ccRCC.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!